Cosmos Health stock trades at USD 0.44 as filings remain central

Cosmos Health stock (ISIN US22143K1016) traded at USD 0.44 on the Nasdaq on September 22, 2026. The 52-week range was USD 0.31 to USD 1.42, leaving the quotation USD 0.98 below the yearly high and USD 0.13 above the low.

Price remains near yearly low

The distance between the September 22, 2026 quotation and the 52-week high is a concrete measure of the stock's current risk profile. At USD 0.44, the share price stood 69.0 percent below the high of USD 1.42 and 41.9 percent above the low of USD 0.31.

The latest market snapshot also puts the company in the small-cap segment, with market capitalization and trading volume forming the next reference points for liquidity analysis. The quoted price and range are dated to the same Nasdaq market context, avoiding a comparison with a secondary venue.

Reported figures set the baseline

For the operating picture, the most recent reported revenue, earnings and margin figures need to be read with their explicit reporting period rather than with the publication date of a market article. The company publishes investor materials through its investor-relations website, while financial filings provide the period-based record for revenue and profitability.

That distinction matters for COSM because a current share price can move independently of the latest available operating period. The numerical comparison visible in the market data is clear: USD 0.44 is 69.0 percent below the 52-week high of USD 1.42, while the 52-week low of USD 0.31 is 29.5 percent below the quoted price.

Nasdaq quotation stays the reference

Nasdaq is the primary reference venue for Cosmos Health in this article, and USD is the reference currency. The September 22, 2026 price of USD 0.44 therefore provides the closing market anchor for the company, while the 52-week range supplies a dated historical frame for interpreting the quotation.

More news and analyses on Cosmos Health stock